Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan Pei

Showing results (301-310 of 318) with videos related to

Pageof 32
Sort By:
Cell Reports|May 6, 2025
N terminus and C terminus of Arabidopsis P4-ATPase AtALA1 facilitate the detoxification of the mycotoxin deoxynivalenol in wheatFanlong Wang, Mingliang Qiu, Lei Hou, et al.
Oncotarget|February 9, 2018
Urine anti-PLA2R antibody is a novel biomarker of idiopathic membranous nephropathyYu Wang, Yi-Xin He, Tian-Tian Diao, et al.
Nature Communications|November 6, 2021
Arabidopsis P4 ATPase-mediated cell detoxification confers resistance to Fusarium graminearum and Verticillium dahliaeFanlong Wang, Xianbi Li, Yujie Li, et al.
Cancer Research|June 14, 2012
CDK inhibitors upregulate BH3-only proteins to sensitize human myeloma cells to BH3 mimetic therapiesShuang Chen, Yun Dai, Xin-Yan Pei, et al.
Nature Communications|November 28, 2024
Camrelizumab plus apatinib for previously treated advanced adrenocortical carcinoma: a single-arm phase 2 trialYu-Chun Zhu, Zhi-Gong Wei, Jing-Jing Wang, et al.
Oncoimmunology|May 17, 2021
Integrative evaluation of primary and metastatic lesion spectrum to guide anti-PD-L1 therapy of non-small cell lung cancer: results from two randomized studiesSi-Cong Ma, Xin-Ran Tang, Li-Li Long, et al.
Nature Communications|March 4, 2023
CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapyXue Bai, Ze-Qin Guo, Yan-Pei Zhang, et al.
Free Radical Biology & Medicine|February 21, 2026
Radiotherapy disrupts ferroptosis tolerance by reducing DNMT1 levels and uncouples STING silencing in LKB1-deficient lung tumorsYan-Pei Zhang, Fei-Fei Wu, Ze-Nan Wu, et al.
BMC Medicine|October 8, 2024
HLA diversity unveils susceptibility and organ-specific occurrence of second primary cancers: a prospective cohort studyZi-Xuan Rong, Wei Wei, Qin Zeng, et al.
BMC Medicine|January 4, 2023
Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies-pharmacovigilance database analysis with real-world data validationXue-Jun Guo, Xiao-Ting Cai, Zi-Xuan Rong, et al.
Pageof 32

Showing results (301-310 of 318) with videos related to

Sort By:
Pageof 32
Cell Reports|May 6, 2025
N terminus and C terminus of Arabidopsis P4-ATPase AtALA1 facilitate the detoxification of the mycotoxin deoxynivalenol in wheatFanlong Wang, Mingliang Qiu, Lei Hou, et al.
Oncotarget|February 9, 2018
Urine anti-PLA2R antibody is a novel biomarker of idiopathic membranous nephropathyYu Wang, Yi-Xin He, Tian-Tian Diao, et al.
Nature Communications|November 6, 2021
Arabidopsis P4 ATPase-mediated cell detoxification confers resistance to Fusarium graminearum and Verticillium dahliaeFanlong Wang, Xianbi Li, Yujie Li, et al.
Cancer Research|June 14, 2012
CDK inhibitors upregulate BH3-only proteins to sensitize human myeloma cells to BH3 mimetic therapiesShuang Chen, Yun Dai, Xin-Yan Pei, et al.
Nature Communications|November 28, 2024
Camrelizumab plus apatinib for previously treated advanced adrenocortical carcinoma: a single-arm phase 2 trialYu-Chun Zhu, Zhi-Gong Wei, Jing-Jing Wang, et al.
Oncoimmunology|May 17, 2021
Integrative evaluation of primary and metastatic lesion spectrum to guide anti-PD-L1 therapy of non-small cell lung cancer: results from two randomized studiesSi-Cong Ma, Xin-Ran Tang, Li-Li Long, et al.
Nature Communications|March 4, 2023
CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapyXue Bai, Ze-Qin Guo, Yan-Pei Zhang, et al.
Free Radical Biology & Medicine|February 21, 2026
Radiotherapy disrupts ferroptosis tolerance by reducing DNMT1 levels and uncouples STING silencing in LKB1-deficient lung tumorsYan-Pei Zhang, Fei-Fei Wu, Ze-Nan Wu, et al.
BMC Medicine|October 8, 2024
HLA diversity unveils susceptibility and organ-specific occurrence of second primary cancers: a prospective cohort studyZi-Xuan Rong, Wei Wei, Qin Zeng, et al.
BMC Medicine|January 4, 2023
Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies-pharmacovigilance database analysis with real-world data validationXue-Jun Guo, Xiao-Ting Cai, Zi-Xuan Rong, et al.
Pageof 32